105 related articles for article (PubMed ID: 9605411)
21. Monoclonal anti-idiotype antibodies recognizing the variable region of a high-affinity antibody against 11-deoxycortisol. Production, characterization and application to a sensitive noncompetitive immunoassay.
Kobayashi N; Shibusawa K; Kubota K; Hasegawa N; Sun P; Niwa T; Goto J
J Immunol Methods; 2003 Mar; 274(1-2):63-75. PubMed ID: 12609533
[TBL] [Abstract][Full Text] [Related]
22. Effects of ursodeoxycholic acid on conjugated bile acids and progesterone metabolites in serum and urine of patients with intrahepatic cholestasis of pregnancy.
Meng LJ; Reyes H; Palma J; Hernandez I; Ribalta J; Sjövall J
J Hepatol; 1997 Dec; 27(6):1029-40. PubMed ID: 9453429
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of ursodeoxycholic acid in rat.
Roda A; Hrelia P; Paolini M; Calzolari M; Grigolo B; Simoni P; Aldini R; Forti GC
Pharmacol Res; 1991 May; 23(4):327-35. PubMed ID: 1876573
[TBL] [Abstract][Full Text] [Related]
24. Production and characterization of monoclonal antibodies against 17alpha-hydroxyprogesterone.
Chong H; Cheah SH; Ragavan M; Johgalingam VT
Hybridoma (Larchmt); 2006 Feb; 25(1):34-40. PubMed ID: 16475880
[TBL] [Abstract][Full Text] [Related]
25. Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis.
Lindor KD; Lacerda MA; Jorgensen RA; DeSotel CK; Batta AK; Salen G; Dickson ER; Rossi SS; Hofmann AF
Am J Gastroenterol; 1998 Sep; 93(9):1498-504. PubMed ID: 9732932
[TBL] [Abstract][Full Text] [Related]
26. Evidence for bile acid glucosides as normal constituents in human urine.
Marschall HU; Egestad B; Matern H; Matern S; Sjövall J
FEBS Lett; 1987 Mar; 213(2):411-4. PubMed ID: 2951276
[TBL] [Abstract][Full Text] [Related]
27. Production and characterization of a monoclonal antibody to capture proteins tagged with lithocholic acid.
Ikegawa S; Yamamoto T; Miyashita T; Okihara R; Ishiwata S; Sakai T; Chong RH; Maeda M; Hofmann AF; Mitamura K
Anal Sci; 2008; 24(11):1475-80. PubMed ID: 18997378
[TBL] [Abstract][Full Text] [Related]
28. The major metabolites of ursodeoxycholic acid in human urine are conjugated with N-acetylglucosamine.
Marschall HU; Griffiths WJ; Götze U; Zhang J; Wietholtz H; Busch N; Sjövall J; Matern S
Hepatology; 1994 Oct; 20(4 Pt 1):845-53. PubMed ID: 7927225
[TBL] [Abstract][Full Text] [Related]
29. Enzyme-linked immunosorbent assay and flow cytometric methods to screen hybridoma culture supernatants for antibodies to bovine neutrophil surface antigens, and monoclonal antibody production and characterization.
Salgar SK; Paape MJ; Alston-Mills B
Am J Vet Res; 1993 Sep; 54(9):1415-25. PubMed ID: 8239127
[TBL] [Abstract][Full Text] [Related]
30. The profile of bile acids and their sulfate metabolites in human urine and serum.
Bathena SP; Mukherjee S; Olivera M; Alnouti Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 942-943():53-62. PubMed ID: 24212143
[TBL] [Abstract][Full Text] [Related]
31. Regurgitation of bile acids in rat liver under bile drainage: quantitative analysis by taurine or ursodeoxycholate loading test.
Nakashima T; Nakagawa Y; Sano A; Sakamoto Y; Shima T; Nakajima T; Seto Y; Okuno T; Kashima K
J Gastroenterol Hepatol; 1990; 5(2):121-5. PubMed ID: 2103392
[TBL] [Abstract][Full Text] [Related]
32. Production of a hybridoma cell line secreting retinoic acid-specific monoclonal antibody.
Zhou HR; Abouzied MM; Zile MH
J Immunol Methods; 1991 Apr; 138(2):211-23. PubMed ID: 2033274
[TBL] [Abstract][Full Text] [Related]
33. Production and characterization of a monoclonal antibody against sterigmatocystin.
Lou JL; Guo ZQ; Meng ZH
Biomed Environ Sci; 1996 Mar; 9(1):17-25. PubMed ID: 8721623
[TBL] [Abstract][Full Text] [Related]
34. Enrichment of bile with tauroursodeoxycholic acid and biliary cholesterol saturation in hamsters.
Handelsman B; Bonorris G; Marks JW; Schoenfield LJ
Am J Physiol; 1982 Nov; 243(5):G424-7. PubMed ID: 7137357
[TBL] [Abstract][Full Text] [Related]
35. A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease.
Lindblad A; Glaumann H; Strandvik B
Hepatology; 1998 Jan; 27(1):166-74. PubMed ID: 9425933
[TBL] [Abstract][Full Text] [Related]
36. Production of monoclonal antibody for okadaic acid and its utilization in an ultrasensitive enzyme-linked immunosorbent assay and one-step immunochromatographic strip.
Liu BH; Hung CT; Lu CC; Chou HN; Yu FY
J Agric Food Chem; 2014 Feb; 62(6):1254-60. PubMed ID: 24446876
[TBL] [Abstract][Full Text] [Related]
37. [Conjugated bile acid profiles in serum, urine, and bile of patients with primary biliary cirrhosis under the ursodeoxycholic acid treatment].
Aoshima M; Nakamura K; Makino I
Hokkaido Igaku Zasshi; 1995 Jan; 70(1):57-67. PubMed ID: 7744371
[TBL] [Abstract][Full Text] [Related]
38. Potential bile acid metabolites. 23. Syntheses of 3-glucosides of nonamidated and glycine- and taurine-amidated bile acids.
Iida T; Nishida S; Yamaguchi Y; Kodake M; Chang FC; Niwa T; Goto J; Nambara T
J Lipid Res; 1995 Mar; 36(3):628-38. PubMed ID: 7775874
[TBL] [Abstract][Full Text] [Related]
39. Intestinal absorption of the bile acid analogue 75Se-homocholic acid-taurine is increased in primary biliary cirrhosis, and reverts to normal during ursodeoxycholic acid administration.
Lanzini A; De Tavonatti MG; Panarotto B; Scalia S; Mora A; Benini F; Baisini O; Lanzarotto F
Gut; 2003 Sep; 52(9):1371-5. PubMed ID: 12912872
[TBL] [Abstract][Full Text] [Related]
40. Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: biliary enrichment and biochemical response.
van de Meeberg PC; Wolfhagen FH; Van Berge-Henegouwen GP; Salemans JM; Tangerman A; van Buuren HR; van Hattum J; van Erpecum KJ
J Hepatol; 1996 Dec; 25(6):887-94. PubMed ID: 9007717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
